Research to Prevent Blindness (RPB) provides major eye research funding to more than 50 leading scientific institutions in the U.S. and supports the work of hundreds of talented vision scientists engaged in a diverse range of disease-oriented research.
The spring cycle grants include new Low Vision Research Awards.
RPB-supported vision researchers at Washington University School of Medicine in St. Louis have contributed key data to a new study that identifies a natural compound that slows typical signs of aging in mice.
Twenty-two emerging vision scientists conducted Capitol Hill visits with NAEVR and RPB to champion federal funding for critical vision research.
A common pathway involved in photoreceptor death has been identified in retinitis pigmentosa, advanced dry age-related macular degeneration and other retinal diseases, with early evidence of a possible halt to vision loss related to pathway treatment.
The National Academies of Sciences, Engineering, and Medicine issues nine concrete recommendations for improving eye and vision health and increasing health equity.
Researchers publish critical findings from Zika mouse model, raising the possibility of new avenues of transmission, as well as confirming the virus’ ability to induce cell death in eyes.
Research initiative to address urgent needs in understanding and treating low vision.
|General Info||Research Scientists & Grantees||Eye Care Specialists||Donors & Partners|